SNT 4.76% 4.4¢ syntara limited

Ann: Commencement of Bronchiectasis Study and Ali, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 164 Posts.
    lightbulb Created with Sketch. 35
    re: Ann: Commencement of Bronchiectasis Study... Australia might be a small market but I want bronchitol available in chemists asap. I currently obtain the drug on compassionate grounds from the Epworth hospital in Melbourne to treat my bronchiectasis. The drug works for me and my only concern is that if the drug does not get approved in Australia I may no longer get access?.

    I am also a holder of pxs and running out of patience.

    I see the postive coverage in the AFR the last few days though.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.002(4.76%)
Mkt cap ! $60.41M
Open High Low Value Volume
4.4¢ 4.5¢ 4.3¢ $22.26K 507.9K

Buyers (Bids)

No. Vol. Price($)
1 27579 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 89528 1
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.